HR 61
urging Congress to amend the federal Food, Drug, and Cosmetic Act and the Public Health Service Act to facilitate the development and approval of new drugs and biologics.
Status: Adopted by the House
This page draws the record — sponsors, votes, hearings, committee reports and the bill text — in the browser, so it needs JavaScript. Everything it shows comes from the files linked below, which need none.
All bills